| PERIOD ENDING | 31-Aug-09 | 31-Aug-08 | 31-Aug-07 | | Total Revenue | 11,684,538 | 12,779,703 | 12,290,592 | | Cost of Revenue | 10,965,723 | 11,911,902 | 11,478,562 | | | Gross Profit | 718,815 | 867,801 | 812,030 | | | Operating Expenses | | Research Development | 27,321 | 32,984 | 36,381 | | Selling General and Administrative | 495,941 | 491,324 | 491,967 | | Non Recurring | 1,074,715 | 54,808 | 72,396 | | Others | 31,039 | 37,288 | 29,347 | | | | Total Operating Expenses | 1,629,016 | 616,404 | 630,091 | | | | Operating Income or Loss | (910,201) | 251,397 | 181,939 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (12,685) | 112 | (1,357) | | Earnings Before Interest And Taxes | (922,886) | 251,509 | 180,582 | | Interest Expense | 82,247 | 94,316 | 86,069 | | Income Before Tax | (1,005,133) | 157,193 | 94,513 | | Income Tax Expense | 160,898 | 25,119 | 21,401 | | Minority Interest | 819 | 1,818 | 124 | | | | Net Income From Continuing Ops | (1,165,212) | 133,892 | 73,236 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,165,212) | 133,892 | 73,236 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,165,212) | $133,892 | $73,236 |
|
1.48% Nasdaq 
Income Statement
